{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T22:51:14Z","timestamp":1763765474409,"version":"3.30.2"},"reference-count":283,"publisher":"Elsevier","isbn-type":[{"type":"print","value":"9780120224753"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2000]]},"DOI":"10.1016\/s0065-2776(00)75006-1","type":"book-chapter","created":{"date-parts":[[2004,5,19]],"date-time":"2004-05-19T04:26:52Z","timestamp":1084940812000},"page":"235-282","source":"Crossref","is-referenced-by-count":120,"title":["Strategies for immunotherapy of cancer"],"prefix":"10.1016","author":[{"given":"Cornelis J.M.","family":"Melief","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ren\u00e9E.M.","family":"Toes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan Paul","family":"Medema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sjoerd H.","family":"Van Der Burg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferry","family":"Ossendorp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rienk","family":"Offringa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S0065-2776(00)75006-1_BIB1","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/(SICI)1097-0215(19990730)82:3<442::AID-IJC19>3.0.CO;2-Z","article-title":"Interleukin-2-induced, melanoma-specific T cells recognize CAMEL, an unexpected translation product of LAGE-1","volume":"82","author":"Aarnoudse","year":"1999","journal-title":"Int. J. Cancer"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB2","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s002620050511","article-title":"Unresponsiveness to interferon associated with STAT1 protein deficiency in a gastric adenocarcinoma cell line","volume":"47","author":"Abril","year":"1998","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB3","first-page":"4079","article-title":"Expression of MUC1 mucin on activated human T cells: Implications for a role of MUC1 in normal immune regulation","volume":"58","author":"Agrawal","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB4","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1084\/jem.189.1.169","article-title":"DNA vaccination: Transfection and activation of dendritic cells as key events for immunity","volume":"189","author":"Akbari","year":"1999","journal-title":"J. Exp. Med."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB5","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/3315","article-title":"Tumor-specific killer cells in paraneoplastic cerebellar degeneration","volume":"4","author":"Albert","year":"1998","journal-title":"Nature Med."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB6","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1084\/jem.188.7.1359","article-title":"Immature dendritic cells phagocytose apoptotic cells via \u03b1v\u03b25 and CD36, and cross-present antigens to CTL","volume":"188","author":"Albert","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB7","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/32183","article-title":"Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs","volume":"392","author":"Albert","year":"1998","journal-title":"Nature"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB8","series-title":"Consequences of depleting CD4+T cells","first-page":"3980","article-title":"Cellular events in the lymph node and lung with influenza","volume":"144","author":"Allan","year":"1990"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB9","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/0952-7915(94)90120-1","article-title":"CD28-B7 interactions in T cell activation","volume":"6","author":"Allison","year":"1994","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB10","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1126\/science.274.5284.94","article-title":"Phenotypic analysis of antigen specific T lymphocytes","volume":"274","author":"Altman","year":"1996","journal-title":"Science"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB11","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0092-8674(00)81031-4","article-title":"Impaired negative selection of T cells in Hodgkin's disease antigen CD30-deficient mice","volume":"84","author":"Amakawa","year":"1996","journal-title":"Cell"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB12","doi-asserted-by":"crossref","first-page":"5211","DOI":"10.4049\/jimmunol.159.11.5211","article-title":"Induction of HLA-A2-restricted CTLs to the mucin 1 human breast cancer antigen","volume":"159","author":"Apostolopoulos","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB13","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1172\/JCI1268","article-title":"Suppression of GVHD and amplification of graft versus tumor effects by activated NK cells after allogeneic bone marrow transplantation","volume":"101","author":"Asai","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB14","first-page":"5330","article-title":"Generation of antimelanoma cytotoxic T lymphocytes from healthy donors after presentation of melanoma-associated antigen-derived epitopes by dendritic cells in vitro","volume":"55","author":"Bakker","year":"1995","journal-title":"Cancer Res."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB15","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.4049\/jimmunol.164.4.1898","article-title":"Flanking amino acids influence C-terminal cleavage preference for CTL epitope generation by the 20S proteasome","volume":"164","author":"Beekman","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB16","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/377630a0","article-title":"A role for CD95 ligand in preventing graft rejection","volume":"377","author":"Bellgrau","year":"1995","journal-title":"Nature"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB17","first-page":"13812","article-title":"Characteristics of virus-specific CD8+ T cells in the liver during the control and resolution phases of influenza pneumonia","volume":"95","author":"Belz","year":"1998"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB18","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/j.1399-0039.1998.tb03082.x","article-title":"Mutations of the \u03b22-microglobulin gene result in a lack of HLAclass I molecules on melanoma cells of two patients immunized with MAGEpeptides","volume":"52","author":"Benitez","year":"1998","journal-title":"Tissue Antigens"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB19","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1084\/jem.186.1.65","article-title":"Induction of a CD8+ CTL response by crosspriming requires cognate CD4+ T cell help","volume":"186","author":"Bennett","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB20","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/30996","article-title":"Help for cytotoxic T lymphocyte responses is mediated by CD40 signalling","volume":"393","author":"Bennett","year":"1998","journal-title":"Nature"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB21","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1084\/jem.182.3.639","article-title":"Antigen presentation to cytotoxic T lymphocytes in vivo","volume":"182","author":"Bevan","year":"1995","journal-title":"J. Exp. Med"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB22","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/1074-7613(95)90161-2","article-title":"CD28 costimulation can promote T cell survival by enhancing the expressing of BcL-xl","volume":"3","author":"Boise","year":"1995","journal-title":"Immunity"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB23","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1074-7613(00)80629-9","article-title":"Initiation of signal transduction through the TCR requires the peptide multivalent engagement of MHC ligands","volume":"9","author":"Boniface","year":"1998","journal-title":"Immunity"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB24","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1146\/annurev.iy.12.040194.002005","article-title":"Tumor antigens recognized by T lymphocytes","volume":"12","author":"Boon","year":"1994","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB25","first-page":"732","article-title":"Her-2\/neu-derived peptides are tumor-associated antigens expressed by human renal cell and colon carcinoma lines and are recognized by in vitro induced specific cytotoxic T lymphocytes","volume":"58","author":"Brossart","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB26","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1182\/blood.V93.12.4309","article-title":"Identification of HLA-A2-restricted T cell epitopes derived from the MUC1 tumor antigen for broadly applicable vaccine therapies","volume":"93","author":"Brossart","year":"1999","journal-title":"Blood"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB27","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1399-0039.1998.tb02274.x","article-title":"High frequency of altered HLA class I phenotypes in invasive colorectal carcinomas","volume":"52","author":"Cabrera","year":"1998","journal-title":"Tissue Antigens"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB28","series-title":"Humoral and cellular responses elicited by tumor-derived immunoglobulin M and its molecular subunits","first-page":"2825","article-title":"Idiotype vaccination against murine B cell lymphoma","volume":"139","author":"Campbell","year":"1987"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB29","series-title":"Humoral and cellular requirements for the full expression of antitumor immunity","first-page":"1029","article-title":"Idiotype vaccination against murine B cell lymphoma","volume":"145","author":"Campbell","year":"1990"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB30","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1749-6632.1988.tb36325.x","article-title":"Linked recognition of helper and cytotoxic determinants for the generation of CTL","volume":"532","author":"Cassel","year":"1988","journal-title":"Ann. NY Acad. Sci."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB31","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1084\/jem.184.2.747","article-title":"Ligation of CD40 on dendritic cells triggers production of high levels of IL-12 and enhances T cell stimulatory capacity: T-T help via APC activation","volume":"184","author":"Cella","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB32","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S1074-7613(00)80607-X","article-title":"CD30 is a CD40-inducible molecule that negatively regulates CD40-mediated immunoglobulin class switching in non-antigen-selected human B cells","volume":"9","author":"Cerutti","year":"1998","journal-title":"Immunity"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB33","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S0952-7915(97)80087-8","article-title":"Costimulation in T cell responses","volume":"9","author":"Chambers","year":"1997","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB34","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1056\/NEJM199706263362602","article-title":"Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children","volume":"336","author":"Chang","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB35","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/(SICI)1097-0215(19980812)77:4<538::AID-IJC11>3.0.CO;2-2","article-title":"Estimation of the frequencies of anti-MAGE-3 cytolytic T lymphocyte precursors in blood from individuals without cancer","volume":"77","author":"Chaux","year":"1998","journal-title":"Int. J. Cancer"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB36","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1084\/jem.189.5.767","article-title":"Identification of MAGE-3 epitopes presented by HLA-DR molecules to CD4+ T lymphocytes","volume":"189","author":"Chaux","year":"1999","journal-title":"J. Exp. Med."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB37","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S1357-4310(97)01003-4","article-title":"p53 as a target for anti-cancer immunotherapy","volume":"3","author":"Chen","year":"1997","journal-title":"Mol. Med. Today"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB38","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1126\/science.282.5394.1714","article-title":"Regulation of the proinflammatory effects of Fas ligand (CD95L)","volume":"282","author":"Chen","year":"1998","journal-title":"Science"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB39","first-page":"1914","article-title":"A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening","volume":"94","author":"Chen","year":"1997"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB40","first-page":"619","article-title":"Immunohistochemical analysis of the T cell receptor-\u03b2 chain variable regions expressed by T-lymphocytes infiltrating primary human melanoma","volume":"78","author":"Clemente","year":"1998","journal-title":"Lab. Invest."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB41","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1074-7613(00)80585-3","article-title":"Tumor cell responses to IFN\u03b3 affect tumorigenicity and response to IL-12 therapy and antiangiogenesis","volume":"9","author":"Coughlin","year":"1998","journal-title":"Immunity"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB42","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1172\/JCI1555","article-title":"IL-12 and IL-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis","volume":"101","author":"Coughlin","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB43","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0140-6736(93)92485-C","article-title":"Regression of small-cell lung carcinoma in patients with paraneoplastic neuronal antibodies","volume":"341","author":"Darnell","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB44","first-page":"4529","article-title":"Onconeural antigens and the paraneoplastic neurologic disorders: At the intersection of cancer immunity and the brain","volume":"93","author":"Darnell","year":"1996"},{"year":"1999","series-title":"Presentation on Keystone Symposium on Tolerance and Autoimmunity","author":"Davis","key":"10.1016\/S0065-2776(00)75006-1_BIB45"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB46","doi-asserted-by":"crossref","first-page":"551","DOI":"10.4049\/jimmunol.158.2.551","article-title":"Costimulation of CD28-T lymphocytes by 4-1 BB ligand","volume":"158","author":"De Benedette","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB47","first-page":"724","article-title":"Immunization with HPV16 oncoprotein-loaded DC as well as protein in adjuvant induces MHC class I restricted protection to HPV16-induced tumor cells","volume":"58","author":"De Bruijn","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB48","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1099\/0022-1317-77-9-2183","article-title":"T cell proliferative responses against HPV16 E7 oncoprotein are most prominent in cervical intraepithelial neoplasia patients with a persistent viral infection","volume":"77","author":"De Gruijl","year":"1996","journal-title":"J. Gen. Virol."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB49","first-page":"1700","article-title":"Differential T helper responses to HPV16 E7 related to viral clearance or persistence in patients with cervical neoplasia","volume":"58","author":"De Gruijl","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB50","first-page":"2420","article-title":"Detection of a transformation-related antigen in chemically induced sarcomas and other transformed cells of the mouse","volume":"76","author":"Deleo","year":"1979"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB51","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1615\/CritRevImmunol.v18.i1-2.40","article-title":"P53-based immunotherapy of cancer","volume":"18","author":"Deleo","year":"1998","journal-title":"Crit. Rev. Immunol."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB52","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S1074-7613(00)80630-5","article-title":"CD8 expression allows T cell signaling by monomeric peptide-MHC complexes","volume":"9","author":"Delon","year":"1998","journal-title":"Immunity"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB53","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/10495","article-title":"CD40 activation in vivo overcomes peptide-induced peripheral cytotoxic T-lymphocyte tolerance and augments anti-tumor vaccine efficacy","volume":"5","author":"Diehl","year":"1999","journal-title":"Nature Med."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB54","doi-asserted-by":"crossref","first-page":"4766","DOI":"10.4049\/jimmunol.155.10.4766","article-title":"Identification of an HLA-A11-restricted epitope from the tandem repeat domain of the epithelial tumor antigen mucin","volume":"155","author":"Domenech","year":"1995","journal-title":"J. Immunol."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB55","first-page":"14903","article-title":"In vivo priming of T cells against cryptic determinants by dendritic cells exposed to interleukin 6 and native antigen","volume":"95","author":"Drakesmith","year":"1999"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB56","first-page":"3539","article-title":"Vaccination with irradiated tumor cells engineered to secrete murine GM-CSF stimulates potent, specific and long-lasting anti-tumor immunity","volume":"90","author":"Dranoff","year":"1993"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB57","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0960-9822(98)70161-7","article-title":"Direct isolation, phenotyping and cloning of low frequency antigen-specific CTL from peripheral blood","volume":"8","author":"Dunbar","year":"1998","journal-title":"Current Biol."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB58","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s002620050415","article-title":"Tumor-specific T-bodies: Towards clinical application","volume":"45","author":"Eshhar","year":"1997","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB59","first-page":"2943","article-title":"Infiltration of cervical cancer tissue with HPV-specific CTL","volume":"57","author":"Evans","year":"1997","journal-title":"Cancer Res."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB60","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1002\/eji.1830230929","article-title":"Vaccination with CTL epitope containing peptide protects against a tumor induced by HPV16-transformed cells","volume":"23","author":"Feltkamp","year":"1993","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB61","first-page":"5803","article-title":"Direct identification of MHC class I-bound tumor-associated peptide antigens of a renal carcinoma cell line by a novel mass spectrometric method","volume":"58","author":"Flad","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB62","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1182\/blood.V83.10.2787.2787","article-title":"Inhibition of human B-cell lymphoma growth by CD40 stimulation","volume":"83","author":"Funakoshi","year":"1994","journal-title":"Blood"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB63","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1023\/A:1008368500557","article-title":"P53-oriented cancer therapies: Current progress","volume":"10","author":"Gallahger","year":"1999","journal-title":"Ann. Oncol."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB64","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1084\/jem.187.10.1647-b","article-title":"Protective immunity does not correlate with the hierarchy of virus-specific CTL responses to naturally processed peptides","volume":"187","author":"Gallimore","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB65","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/nm0896-925","article-title":"KSHV antibodies among Americans, Italians and Ugenands with and without Kaposi's sarcoma","volume":"2","author":"Gao","year":"1996","journal-title":"Nature Med."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB66","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0065-230X(08)60713-7","article-title":"HLA class I antigens in human tumors","volume":"67","author":"Garrido","year":"1995","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB67","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0167-5699(96)10075-X","article-title":"Implication for immunosurveillance of altered HLA class I phenotypes in human tumours","volume":"18","author":"Garrido","year":"1997","journal-title":"Immunol. Today"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB68","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1126\/science.283.5404.978","article-title":"A giant protease with potential to substitute for some functions of the proteasome","volume":"283","author":"Geier","year":"1999","journal-title":"Science"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB69","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1084\/jem.188.6.1105","article-title":"Major histocompatibility complex class I viral antigen processing in the secretory pathway defined by the trans-Golgi network protease furin","volume":"188","author":"Gil-Torregrosa","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB70","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1002\/1097-0142(196710)20:10<1663::AID-CNCR2820201014>3.0.CO;2-D","article-title":"Circulating antibodies against carcinoembryonic antigens of the human digestive system","volume":"20","author":"Gold","year":"1967","journal-title":"Cancer"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB71","first-page":"6279","article-title":"Reversal of tolerance to human MUC1 antigen in MUC1 transgenic mice immunized with fusions of dendritic and carcinoma cells","volume":"95","author":"Gong","year":"1998"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB72","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1600-065X.1997.tb00978.x","article-title":"Human minor histocompatibility antigens: New concepts for marrow transplantation and adoptive immunotherapy","volume":"157","author":"Goulmy","year":"1997","journal-title":"Immunol. Rev."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB73","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1006\/smim.1998.0144","article-title":"Tumor necrosis factor receptor family members in the immune system","volume":"10","author":"Gravestein","year":"1998","journal-title":"Sem. Immunol."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB74","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0065-2776(08)60778-6","article-title":"Adoptive T cell therapy of tumors: Mechanisms operative in the recognition and elemenation of tumor cells","volume":"49","author":"Greenberg","year":"1991","journal-title":"Adv. Immunol."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB75","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1126\/science.270.5239.1189","article-title":"Fas ligand-induced apoptosis as a mechanism of immune privilege","volume":"270","author":"Griffith","year":"1995","journal-title":"Science"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB76","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.4049\/jimmunol.161.6.2833","article-title":"Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells","volume":"161","author":"Griffith","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB77","doi-asserted-by":"crossref","first-page":"4563","DOI":"10.4049\/jimmunol.161.9.4563","article-title":"CD40 ligand\/trimer DNA enhances both humoral and cellular immune responses and induces protective immunity to infections and tumor challenge","volume":"161","author":"Gurunathan","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB78","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1084\/jem.188.9.1633","article-title":"Potent T cell activation with dimeric peptide-MHC class II ligand: The role of the CD4 coreceptor","volume":"188","author":"Hamad","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB79","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1136\/gut.40.3.356","article-title":"Detection and monitoring of serum p53 antibodies in patients with colorectal cancer","volume":"40","author":"Hammel","year":"1997","journal-title":"Gut"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB80","first-page":"4930","article-title":"Fas and its ligand in a general mechanism of T cell mediafted cytotoxicity","volume":"91","author":"Hanabuchi","year":"1994"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB81","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1084\/jem.187.10.1549","article-title":"Cross-tolerance: A pathway for inducing tolerance to peripheral tissue antigens","volume":"187","author":"Heath","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB82","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1600-065X.1995.tb00079.x","article-title":"Can co-stimulated tumor immunity be therapeutically efficacious?","volume":"145","author":"Hellstr\u00f6m","year":"1995","journal-title":"Immunol. Rev."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB83","series-title":"1-specific CTL","first-page":"10275","article-title":"Direct identification of an endogenous peptide recognized by multiple HLA-A2","volume":"90","author":"Henderson","year":"1993"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB84","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0022-1759(97)00019-7","article-title":"The use of computer-assisted video images for the quantitation of CD8+ T lymphocytes producing TNF\u03b3 spots in response to peptide antigens","volume":"203","author":"Herr","year":"1997","journal-title":"J. Immunol. Meth."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB85","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nm0596-551","article-title":"Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes","volume":"2","author":"Heslop","year":"1996","journal-title":"Nature Med."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB86","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.1002\/(SICI)1521-4141(199811)28:11<3594::AID-IMMU3594>3.0.CO;2-D","article-title":"CD40 induces resistance to TNF-mediated apoptosis in a fibroblast cell line","volume":"28","author":"Hess","year":"1998","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB87","first-page":"517","article-title":"Malignancy after renal transplantation analysis of incidence and risk factors in 1700 patients followed during a 25-year period","volume":"71","author":"Hiesse","year":"1997"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB88","first-page":"5066","article-title":"Naturally processed class II epitope from the tumor antigen MUC1 primes human CD4+ T cells","volume":"58","author":"Hiltbold","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB89","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1182\/blood.V93.9.2999","article-title":"Inhibition of human breast carcinoma growth by a soluble recombinant human CD40 ligand","volume":"93","author":"Hirano","year":"1999","journal-title":"Blood"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB90","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1056\/NEJM199802123380703","article-title":"Natural history of cervicovaginal papillomavirus infection in young women","volume":"338","author":"Ho","year":"1998","journal-title":"N. Eng. J. Med."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB91","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0264-410X(96)00238-1","article-title":"Diversified prime and boost protocols using recombinant vaccinia virus and recombinant nonreplicating avian pox virus to enhance T cell immunity and antitumor responses","volume":"15","author":"Hodge","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB92","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1126\/science.1905840","article-title":"P53 mutations in human cancer","volume":"253","author":"Hollstein","year":"1991","journal-title":"Science"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB93","first-page":"2627","article-title":"Eradication of large human B cell tumors in nude mice with unconjugated CD20 monoclonal antibodies and interleukin-2","volume":"55","author":"Hooijberg","year":"1995","journal-title":"Cancer Res."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB94","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1006\/smim.1998.0156","article-title":"CD30: Expression and function in health and disease","volume":"10","author":"Horie","year":"1998","journal-title":"Semin. Immunol."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB95","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1002\/eji.1830230905","article-title":"In vitro induction of human cytotoxic T Lymphocyte responses against peptides of mutant and wild-type p53","volume":"23","author":"Houbiers","year":"1993","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB96","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/bjc.1995.386","article-title":"Antibodies against p53 are associated with poor prognosis of colorectal cancer","volume":"72","author":"Houbiers","year":"1995","journal-title":"Br. J. Cancer"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB97","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1182\/blood.V89.9.3129","article-title":"Tumor-specific idiotype vaccines in the treatment of patients with B-cell lymphoma\u2014long-term results of a clinical trial","volume":"89","author":"Hsu","year":"1997","journal-title":"Blood"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB98","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/nm0196-52","article-title":"Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells","volume":"2","author":"Hsu","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB99","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1126\/science.7513904","article-title":"Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens","volume":"264","author":"Huang","year":"1994","journal-title":"Science"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB100","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1084\/jem.188.12.2357","article-title":"The central role of CD4+ T cells in anti-tumor immune response","volume":"188","author":"Hung","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB101","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.4049\/jimmunol.158.6.2600","article-title":"Signals through 4-1 BB are costimulatory to previously activated splenic T cells and inhibit activation induced cell death","volume":"158","author":"Hurtado","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB102","first-page":"10067","article-title":"CTLA-4 blockade synergizes with tumor-derived granulocyte-macrophage colony-stimulating factor for treatment of an experimental mammary carcinoma","volume":"95","author":"Hurwitz","year":"1998"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB103","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S1074-7613(00)80426-4","article-title":"Cytolytic T cells expressing NK inhibitory receptor P58.2 recognize on a melanoma metastasis lacking HLA-Cw7, an antigen encoded by a gene which is preferentially expressed in tumors","volume":"6","author":"Ikeda","year":"1997","journal-title":"Immunity"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB104","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/40657","article-title":"Inhibition of death receptor signals by cellular FLIP","volume":"388","author":"Irmler","year":"1997","journal-title":"Nature"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB105","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1093\/jnci\/89.21.1595","article-title":"Enhancing efficacy of recombinant anticancer vaccines with prime\/boost regimens that use two different vectors","volume":"89","author":"Irvine","year":"1997","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB106","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/(SICI)1097-0215(19960703)67:1<54::AID-IJC11>3.0.CO;2-C","article-title":"GM-CSF enhances immune responses to melanoma-associated peptides in vivo","volume":"67","author":"J\u00e4ger","year":"1996","journal-title":"Int. J. Cancer"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB107","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/(SICI)1097-0215(19970410)71:2<142::AID-IJC3>3.0.CO;2-0","article-title":"Immunoselection in vivo: Independent loss of MHC class I and melanocyte differentiation antigen expression in metastative melanoma","volume":"71","author":"J\u00e4ger","year":"1997","journal-title":"Int. J. Cancer"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB108","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1084\/jem.187.2.265","article-title":"Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: Definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes","volume":"187","author":"J\u00e4ger","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB109","first-page":"3660","article-title":"Down-regulation of the transporter for antigen presentation, proteasome subunits and MHC class I in tumor cell lines","volume":"58","author":"Johnson","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB110","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S1074-7613(00)80255-1","article-title":"MHC class I-restricted CTL responses to exogenous antigens","volume":"5","author":"Jondal","year":"1996","journal-title":"Immunity"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB111","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1126\/science.7518614","article-title":"FAS and perforin pathways as major mechanisms of T cell mediated cytotoxicity","volume":"265","author":"K\u00e4gi","year":"1994","journal-title":"Science"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB112","first-page":"7556","article-title":"Demonstration of an interferon-\u03b3 dependent tumor surveillance systems in immunocompetent mice","volume":"95","author":"Kaplan","year":"1998"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB113","first-page":"676","article-title":"Induction of protective host immunity to carcinoembryonic antigen (CEA), a self-antigen in CEA transgenic mice, by immunizing with a recombinant vaccinia-CEA virus","volume":"59","author":"Kass","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB114","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/0092-8674(89)90006-8","article-title":"Eradication of adenovirus E1-induced tumors by E1A-specific cytotoxic T lymphocytes","volume":"59","author":"Kast","year":"1989","journal-title":"Cell"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB115","doi-asserted-by":"crossref","first-page":"3936","DOI":"10.4049\/jimmunol.161.8.3936","article-title":"FLIP prevents apoptosis induced by death receptors but not by perforin\/granzyme B, chemotherapeutic drugs and gamma irradication","volume":"161","author":"Kataoka","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB116","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1038\/nm0896-918","article-title":"The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus: Distribution of infection in KS risk groups and evidence for sexual transmission","volume":"2","author":"Kedes","year":"1996","journal-title":"Nature Med."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB117","doi-asserted-by":"crossref","first-page":"4917","DOI":"10.4049\/jimmunol.155.10.4917","article-title":"Stimulation of CD40 with purified soluble gp39 induces proinflammatory responses in human monocytes","volume":"155","author":"Kiener","year":"1995","journal-title":"J. Immunol."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB118","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/00002371-199707000-00004","article-title":"Dendritic cells infected with poxviruses encoding MART-1\/Melan A sensitize T lymphocytes in vitro","volume":"20","author":"Kim","year":"1997","journal-title":"J. Immunother."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB119","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/(SICI)1521-4141(199803)28:03<881::AID-IMMU881>3.0.CO;2-0","article-title":"Human 4-1 BB regulates CD28 co-stimulation to promote TH1 responses","volume":"28","author":"Kim","year":"1998","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB120","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1006\/cimm.1993.1080","article-title":"Idiotypic IgM on a B-cell surface requires processing for recognition by anti-idiotypic T cells","volume":"147","author":"King","year":"1993","journal-title":"Cell. Immunol"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB121","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/intimm\/5.6.625","article-title":"Activation interferes with the APO-1 pathway in mature human T cells","volume":"5","author":"Klas","year":"1993","journal-title":"Int. Immunol."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB122","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1084\/jem.184.2.741","article-title":"High level IL-12 production by murine dendritic cells: Upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10","volume":"184","author":"Koch","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB123","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00001622-199703000-00006","article-title":"Adoptive immunotherapy with donor lymphocyte transfusions","volume":"9","author":"Kolb","year":"1997","journal-title":"Curr. Opin. Oncol."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB124","first-page":"2856","article-title":"Humoral immunity against a tandem repeat epitope of human mucin MUC-1 in sera from breast, pancreatic and colon cancer patients","volume":"54","author":"Kotera","year":"1994","journal-title":"Cancer Res."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB125","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0065-2776(08)60402-2","article-title":"CD95 (APO-1\/Fas)-mediated apoptosis: Live and let die","volume":"71","author":"Krammer","year":"1999","journal-title":"Adv. Immunol."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB126","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1084\/jem.188.4.619","article-title":"Antigen-dependent CD28 signalling selectively enhances survival and proliferation in genetically modified activated human primary T lymphocytes","volume":"188","author":"Krause","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB127","doi-asserted-by":"crossref","first-page":"3819","DOI":"10.4049\/jimmunol.157.9.3819","article-title":"A subclass of dendritic cells regulates the response of naive CD8 T cells by limiting their IL-2 production","volume":"157","author":"Kronin","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB128","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1084\/jem.186.12.2057","article-title":"CD4+ T cell help impairs CD8+ presentation of self-antigens and favors autoimmunity","volume":"186","author":"Kurts","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB129","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1084\/jem.188.2.415","article-title":"The peripheral deletion of autoreactive CD8+ T cells induced by cross-presentation of self-antigens involves signaling through CD95 (fas, Apo-1)","volume":"188","author":"Kurts","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB130","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/18692","article-title":"Signaling through CD30 protects against autoimmune diabetes mediated by CD8 T cells","volume":"398","author":"Kurts","year":"1999","journal-title":"Nature"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB131","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1093\/oxfordjournals.bmb.a072911","article-title":"p53 and human cancer","volume":"50","author":"Lane","year":"1994","journal-title":"British. Med. Bull."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB132","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1006\/smim.1998.0154","article-title":"Control of lymphocyte function through CD27-CD70 interactions","volume":"10","author":"Lens","year":"1998","journal-title":"Semin. Immunol."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB133","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/(SICI)1097-0215(19980610)76:6<903::AID-IJC22>3.0.CO;2-1","article-title":"LAGE-1, a new gene with tumor specificity","volume":"76","author":"Leth\u00e9","year":"1998","journal-title":"Int. J. Cancer"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB134","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S1074-7613(00)80461-6","article-title":"The duration of antigenic stimulation determines the fate of naive and effector T cells","volume":"8","author":"Lezzi","year":"1998","journal-title":"Immunity"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB135","doi-asserted-by":"crossref","first-page":"6910","DOI":"10.1002\/j.1460-2075.1996.tb01083.x","article-title":"Distinct MHC class II complexes generated by separate processing pathways","volume":"15","author":"Lindner","year":"1996","journal-title":"EMBO J."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB136","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1006\/smim.1998.0159","article-title":"CD27 and TNFR relatives in the immune system: Their role in health and disease","volume":"10","author":"Loenen","year":"1998","journal-title":"Semin. Immunol."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB137","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/370650a0","article-title":"Cytotoxic T cell cytotoxicity is mediated through perforin and FAS lytic pathways","volume":"370","author":"Lowin","year":"1994","journal-title":"Nature"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB138","first-page":"1463","article-title":"P53 antibodies in patients with various types of cancer: Assay, identification and characterization","volume":"1","author":"Lubin","year":"1995","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB139","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nm0795-701","article-title":"Serum p53 antibodies as early markers of lung cancer","volume":"1","author":"Lubin","year":"1995","journal-title":"Nature Med."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB140","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1099\/0022-1317-77-7-1585","article-title":"Proliferative T cell response to the HPV16 E7 protein in women with cervical dysplasia and cervical carcinoma and in healthy individuals","volume":"77","author":"Luxton","year":"1996","journal-title":"J. Gen. Virol."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB141","first-page":"1540","article-title":"Myeloma proteins as tumor-specific transplantation antigens","volume":"69","author":"Lynch","year":"1972"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB142","first-page":"2569","article-title":"Protective immunity induced by tumor vaccines requires interactions between CD40 and its ligand, CD154","volume":"57","author":"Mackey","year":"1997","journal-title":"Cancer Res."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB143","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.4049\/jimmunol.161.5.2094","article-title":"Dendritic cells require maturation via CD40 to generate protective anti-tumor immunity","volume":"161","author":"Mackey","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB144","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.4049\/jimmunol.160.7.3111","article-title":"Intercellular and intracellular events following the MHC-unrestricted TCR recognition of a tumor-specific peptide epitope on the epithelial antigen MUC1","volume":"160","author":"Magarian-Blander","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB145","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1182\/blood.V90.6.2188","article-title":"IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non Hodgkin's lymphoma","volume":"90","author":"Maloney","year":"1997","journal-title":"Blood"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB146","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1084\/jem.189.5.871","article-title":"Melanoma cells present a MAGE-3 epitope to CD4+ CTL in association with histocompatibility leukocyte antigen DR II","volume":"189","author":"Manici","year":"1999","journal-title":"J. Exp. Med."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB147","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/25379","article-title":"An asparaginyl endopeptidase processes a microbial antigen for class II MHCpresentation","volume":"396","author":"Manoury","year":"1998","journal-title":"Nature"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB148","first-page":"1921","article-title":"Analysis and sorting of live cells according to secreted molecules, relocated to a cell-surface affinity matrix","volume":"92","author":"Manz","year":"1995"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB149","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/ijc.2910630622","article-title":"Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3","volume":"63","author":"Marchand","year":"1995","journal-title":"Int. J. Cancer"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB150","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1200\/JCO.1999.17.1.332","article-title":"Phase I study in cancer patients of a replication-defective Avipox recombinant vaccine that expresses human carcinoembryonic antigen","volume":"17","author":"Marshall","year":"1999","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB151","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1146\/annurev.iy.12.040194.005015","article-title":"Tolerance, danger, and the extended family","volume":"12","author":"Matzinger","year":"1994","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB152","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1006\/smim.1998.0143","article-title":"An innate sense of danger","volume":"10","author":"Matzinger","year":"1998","journal-title":"Semin. Immunol."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB153","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1038\/nm1295-1297","article-title":"Bone-marrow-derived DC pulsed with synthetic tumour peptides elicits protective and therapeutic anti-tumour immunity","volume":"1","author":"Mayordomo","year":"1995","journal-title":"Nature Med."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB154","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/00002371-199801000-00005","article-title":"Induction of protective anti-tumor immunity by gene-modified dendritic cells","volume":"21","author":"McArthur","year":"1998","journal-title":"J. Immunother."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB155","first-page":"703","article-title":"Rapid production of specific vaccines for lymphoma by expression of the tumor-derived single-chain Fv epitopes in tobacco plants","volume":"96","author":"McCormick","year":"1999"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB156","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1084\/jem.190.7.1033","article-title":"Immune escape of tumors in vivo by expression of C-FLIP","volume":"190","author":"Medema","year":"1999","journal-title":"J. Exp. Med."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB157","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nm0697-682","article-title":"Monoclonal antibodies against the 4-1 BB T cell activation molecule eradicate established tumors","volume":"3","author":"Melero","year":"1997","journal-title":"Nature Med."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB158","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0065-230X(08)60294-8","article-title":"Tumor eradication by adoptive transfer of cytotoxic T lymphocytes","volume":"58","author":"Melief","year":"1992","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB159","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1002\/(SICI)1521-4141(199806)28:06<1923::AID-IMMU1923>3.0.CO;2-9","article-title":"Dendritic cell\/macrophage precursors capture exogenous antigen for MHC class I presentation by dendritic cells","volume":"28","author":"Mitchell","year":"1998","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB160","first-page":"3891","article-title":"Allogeneic cell therapy for a murine mammary carcinoma","volume":"58","author":"Morecki","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB161","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1002\/(SICI)1521-4141(199811)28:11<3685::AID-IMMU3685>3.0.CO;2-3","article-title":"In vitro induction of CTL with complexes of peptide and recombinant MHC class I molecules coated onto beads: Role of TCR\/ligand density","volume":"28","author":"Motta","year":"1998","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB162","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4049\/jimmunol.162.1.25","article-title":"Alloreactivity as a source of high avidity peptide-specific human CTL","volume":"162","author":"M\u00fcnz","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB163","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1074-7613(00)80470-7","article-title":"Counting antigen-specific CD8 T cells: A reevaluation of bystander activation during viral infection","volume":"8","author":"Murali-Krishna","year":"1998","journal-title":"Immunity"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB164","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1182\/blood.V86.5.1946.bloodjournal8651946","article-title":"Antibodies to CD40 prevent Epstein-Barr virus-mediated human B cell lymphomagenesis in SCID mice given human PBL","volume":"86","author":"Murphy","year":"1995","journal-title":"Blood"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB165","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1182\/blood.V93.7.2336","article-title":"Feasibility of immunotherapy of relapsed leukemia with ex vivogenerated CTL specific for hematopoietic system-restricted minor histocompatibility antigens","volume":"93","author":"Mutis","year":"1999","journal-title":"Blood"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB166","first-page":"193","article-title":"Enhancement of antitumor immunity by engaging the OX40 receptor (CD134) in vivo","volume":"3610","author":"Muy-Rivera","year":"1998"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB167","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0092-8674(00)81874-7","article-title":"Apoptosis by death factor","volume":"88","author":"Nagata","year":"1997","journal-title":"Cell"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB168","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/nbt0498-364","article-title":"Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA","volume":"16","author":"Nair","year":"1998","journal-title":"Nat. Biotechnol"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB169","first-page":"3491","article-title":"CD8+ T cells infiltrated within cancer cells nests as a prognostic factor in human colorectal cancer","volume":"58","author":"Naito","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB170","first-page":"628","article-title":"Amino-terminal trimming of peptides for presentation on major histocompatibility complex class II molecules","volume":"94","author":"Nelson","year":"1997"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB171","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nm0398-328","article-title":"Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells","volume":"4","author":"Nestl\u00e9","year":"1998","journal-title":"Nature Med."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB172","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S0140-6736(98)22009-5","article-title":"Assessment of risk of cancer after renal transplantation","volume":"351","author":"Newstead","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB173","first-page":"12504","article-title":"Cleavage motifs of the yeast 20S proteasome \u03b2 subunits deduced from digest of enolase 1","volume":"95","author":"Nussbaum","year":"1998"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB174","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1002\/(SICI)1521-4141(199808)28:08<2432::AID-IMMU2432>3.0.CO;2-0","article-title":"Allo- and self-restricted CTL against a peptide library: Evidence for a functionally diverse allo-restricted T cell repertoire","volume":"28","author":"Obst","year":"1998","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB175","first-page":"447","article-title":"T cell-mediated immunotherapy of cancer","author":"Offringa","year":"1999"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB176","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1084\/jem.188.6.1203","article-title":"High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in Autoimmune Vitiligo","volume":"188","author":"Ogg","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB177","first-page":"445","article-title":"Adoptive immunotherapy for Epstein-Barr virus-associated lympho-proliferative disorders complicating marrow allografts","volume":"20","author":"O'Reilly","year":"1998","journal-title":"Springer Semin. Immuno-Pathol."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB178","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/00002371-199508000-00002","article-title":"Dendritic cells as carriers for a CTL epitope-based peptide vaccine in protection against an HPV16 induced tumor","volume":"18","author":"Ossevoort","year":"1995","journal-title":"J. Immunother."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB179","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S1074-7613(00)80488-4","article-title":"A single residue exchange within a viral CTL epitope alters proteasome-mediated degradation resulting in lack of antigen presentation","volume":"5","author":"Ossendorp","year":"1996","journal-title":"Immunity"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB180","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1084\/jem.187.5.693","article-title":"Specific T helper cell requirement for optimal induction of CTL against MHC class II-negative tumors","volume":"187","author":"Ossendorp","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB181","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1084\/jem.188.2.277","article-title":"Gp100\/pmel 17 is a murine tumor rejection antigen: Induction of \u201cself\u201d reactive, tumoricidal T cells using high-affinity, altered peptide ligand","volume":"188","author":"Overwijk","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB182","first-page":"2982","article-title":"Vaccination with a recombinant vaccinia virus encoding a \u201celf\u201d antigen induces autoimmune vitiligo and tumor cell destruction in mice: Requirement for CD4+ T lymphocytes","volume":"96","author":"Overwijk","year":"1999"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB183","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1084\/jem.188.9.1717","article-title":"Fas and Fas ligand interactions suppress melanoma","volume":"188","author":"Owen-Schaub","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB184","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S1074-7613(00)80628-7","article-title":"Comparison of activation versus induction of unresponsiveness of virus-specific CD4+ and CD8+ T cells upon acute versus peristent viral infection","volume":"9","author":"Oxenius","year":"1998","journal-title":"Immunity"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB185","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nm0598supp-525","article-title":"Cancer vaccines","volume":"4","author":"Pardoll","year":"1998","journal-title":"Nature Med."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB186","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1002\/eji.1830270523","article-title":"Resistance of cultured peripheral T cells towards activation-induced cell death involves a lack of recruitment of FLICE (MACH\/caspase 8) to the CD95 death-inducing signaling complex","volume":"27","author":"Peter","year":"1997","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB187","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.4049\/jimmunol.161.5.2099","article-title":"Constitutive IL-10 production accounts for the high NK sensitivity, low MHC class I expression and poor TAP 1\/2 function in the prototype NK target YAC-1","volume":"161","author":"Petersson","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB188","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1084\/jem.189.5.757","article-title":"Biochemical indentification of a mutated human melanoma antigen recognized by CD4+ T cells","volume":"189","author":"Pieper","year":"1999","journal-title":"J. Exp. Med."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB189","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/25387","article-title":"Genomic amplification of a decoy receptor for FAS ligand in lung and colon cancer","volume":"396","author":"Pitty","year":"1998","journal-title":"Nature"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB190","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1084\/jem.188.6.1075","article-title":"Predominant role for directly transfected dendritic cells in antigen presentation of CD8+ T cells after gene gun immunization","volume":"188","author":"Porgador","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB191","first-page":"1486","article-title":"Reduction of established spontaneous mammary carcinoma metastases following immunotherapy with MHC class II and B7.1 cell based tumor vaccines","volume":"58","author":"Pulaski","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB192","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/(SICI)1097-0215(19980119)75:2<317::AID-IJC23>3.0.CO;2-8","article-title":"In vivo and in vitro generation of a new altered HLA phenotype in melanoma-tumour-cell variants expressing a single HLA-class-I allele","volume":"75","author":"Real","year":"1998","journal-title":"Int. J. Cancer"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB193","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1182\/blood.V93.7.2411","article-title":"Idiotype vaccination using dendritic cells after autologous peripheral blood stem cell transplantation for multiple myeloma\u2014A feasibility study","volume":"93","author":"Reichardt","year":"1999","journal-title":"Blood"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB194","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S0952-7915(97)80096-9","article-title":"Alternative antigen processing pathways in anti-infective immunity","volume":"9","author":"Reimann","year":"1997","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB195","first-page":"582","article-title":"Occasional memory CTL responses of patients with human HPV-16 positive cervical lesions against a human HlA-A*0201 restricted E7 encoded epitope","volume":"56","author":"Ressing","year":"1996","journal-title":"Cancer Res."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB196","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/00001622-199901000-00012","article-title":"Recent progress toward the development of recombinant and synthetic vaccines for the treatment of melanoma","volume":"11","author":"Restifo","year":"1999","journal-title":"Curr. Opin. Oncol."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB197","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1002\/(SICI)1521-4141(199806)28:06<2003::AID-IMMU2003>3.0.CO;2-S","article-title":"Th1 cells induce and Th2 inhibit antigen-dependent IL-12 secretion by dendritic cells","volume":"28","author":"Ria","year":"1998","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB198","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/30989","article-title":"A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell","volume":"393","author":"Ridge","year":"1998","journal-title":"Nature"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB199","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1200\/JCO.1998.16.5.1788","article-title":"Monoclonal antibody therapy for resected Duke's C colorectal cancer: Seven year outcome of a multicenter randomized trial","volume":"16","author":"Riethm\u00fcller","year":"1998","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB200","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0167-5699(96)80605-0","article-title":"A new foreign policy: MHC class I molecules monitor the outside world","volume":"17","author":"Rock","year":"1996","journal-title":"Immunol. Today"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB201","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S1357-4310(98)01280-5","article-title":"Novel methods to monitor antigen-specific CTL responses in cancer immunotherapy","volume":"4","author":"Romero","year":"1998","journal-title":"Mol. Med. Today"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB202","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1084\/jem.188.9.1641","article-title":"Ex vivo staining of metastatic lymph nodes by MHC class I tetramers reveals high numbers of antigen-experienced tumor-specific CTL","volume":"188","author":"Romero","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB203","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.4049\/jimmunol.163.2.1037","article-title":"Identification of new HER2\/neu-derived peptide epitopes that can elicit specific CTL against autologous and allogeneic carcinomas and melanomas","volume":"163","author":"Rongcun","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB204","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1182\/blood.V92.5.1549","article-title":"Infusion of CTL for the prevention and treatment of EBV-induced lymphoma in allogeneic transplant recipients","volume":"92","author":"Rooney","year":"1998","journal-title":"Blood"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB205","first-page":"14704","article-title":"Spontaneous human squamous cell carcinomas are killed by a human cytotoxic T lymphocyte clone recognizing a wild-type p53-derived peptide","volume":"93","author":"R\u00f6pke","year":"1996"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB206","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1093\/jnci\/86.15.1159","article-title":"Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and IL-2","volume":"86","author":"Rosenberg","year":"1994","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB207","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nm0398-321","article-title":"Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma","volume":"4","author":"Rosenberg","year":"1998","journal-title":"Nature Med."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB208","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S1074-7613(00)80028-X","article-title":"A new era for cancer immunotherapy based on the genes that encode cancer antigens","volume":"10","author":"Rosenberg","year":"1999","journal-title":"Immunity"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB209","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0145-2126(99)00045-4","article-title":"Autoimmune disease induced by dendritic cell immunization against leukemia","volume":"23","author":"Roskrow","year":"1999","journal-title":"Leuk. Res."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB210","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0167-5699(98)01349-8","article-title":"HLA and cancer: From research to clinical impact","volume":"19","author":"Ruiz-Cabello","year":"1998","journal-title":"Immunol. Today"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB211","first-page":"13114","article-title":"Peptide-specific cytotoxic T lymphocytes restricted by nonself major histocompatibility complex class I molecules: Reagents for tumor immunotherapy","volume":"93","author":"Sadovnikova","year":"1996"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB212","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/(SICI)1521-4141(199801)28:01<193::AID-IMMU193>3.0.CO;2-K","article-title":"Generation of human tumor-reactive cytotoxic T cells against peptides presented by non-self HLA class I molecules","volume":"28","author":"Sadovnikova","year":"1998","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB213","first-page":"11810","article-title":"Human neoplasms elicit multiple specific immune responses in the autologous host","volume":"92","author":"Sahin","year":"1995"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB214","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1084\/jem.189.4.611","article-title":"Mobilizing dendritic cells for tolerance, priming and chronic inflammation","volume":"189","author":"Sallusto","year":"1999","journal-title":"J. Exp. Med."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB215","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s002620050513","article-title":"Pharmacological administration of granulocyte\/macrophage-colony-stimulating factor is of significant importance for the induction of a strong humoral and cellular response in patients immunized with recombinant careinoembryonic antigen","volume":"47","author":"Samanci","year":"1998","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB216","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1084\/jem.187.11.1849","article-title":"CD28-independent, TRAF2-dependent costimulation of resting T cells by 4-1 BB ligand","volume":"187","author":"Saoulli","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB217","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1074\/jbc.274.3.1541","article-title":"The role of c-FLIP in modulation of CD95-induced apoptosis","volume":"274","author":"Scaffidi","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB218","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1093\/emboj\/17.6.1675","article-title":"Two CD95 (APO-1\/FAS) signalling pathways","volume":"17","author":"Scaffidi","year":"1998","journal-title":"EMBO J."},{"year":"2000","series-title":"Identification of tumor-associated MHC class I ligands by a novel T cell independent approach","author":"Schirle","key":"10.1016\/S0065-2776(00)75006-1_BIB219"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB220","doi-asserted-by":"crossref","first-page":"4149","DOI":"10.1002\/(SICI)1521-4141(199812)28:12<4149::AID-IMMU4149>3.0.CO;2-D","article-title":"Similar as well as distinct MHC class I-binding peptides are generated by exogenous and endogenous processing of hepatitis B virus surface antigen","volume":"28","author":"Schirmbeck","year":"1998","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB221","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1006\/smim.1996.0039","article-title":"Harnessing self-reactivity in cancer immunotherapy","volume":"8","author":"Schoenberger","year":"1996","journal-title":"Semin. Immunol."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB222","first-page":"3094","article-title":"Efficient direct priming of tumor-specific CTL in vivo by an engineered APC","volume":"58","author":"Schoenberger","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB223","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/31002","article-title":"T cell help for cytotoxic T lymphocyte responses is mediated by CD40-CD40 L interactions","volume":"393","author":"Schoenberger","year":"1998","journal-title":"Nature"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB224","first-page":"2509","article-title":"Genetic vaccination against the melanocyte lineage-specific antigen gp100 induces CTL-mediated tumor protection","volume":"58","author":"Schreurs","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB225","first-page":"5250","article-title":"Successful immunotherapy of an intraocular tumor in mice","volume":"59","author":"Schurmans","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB226","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1084\/jem.178.3.933","article-title":"A tumor escape variant that has lost one MHC class I restriction element induces specific CD8+ T cells to an antigen that no longer serves as a target","volume":"178","author":"Seung","year":"1993","journal-title":"J. Exp. Med."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB227","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/nm0898-939","article-title":"A minimal glycine-alanine repeat prevents the interaction of ubiquitinated I\u03ba\u03b2\u03b1 with the proteasome: A new mechanism for selective inhibition of proteolysis","volume":"4","author":"Shapiro","year":"1998","journal-title":"Nature Med."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB228","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1615\/CritRevImmunol.v18.i1-2.60","article-title":"Strategies for tumor elimination by cytotoxic T lymphocytes","volume":"18","author":"Sherman","year":"1998","journal-title":"Crit. Rev. Immunol."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB229","series-title":"ICAM-1 as the second costimulatory molecule rapidly upregulated by CD40L","first-page":"2764","article-title":"CD40L is important for induction of, but not response to, costimulatory activity","volume":"157","author":"Shinde","year":"1996"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB230","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/18038","article-title":"CTL immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen","volume":"398","author":"Sigal","year":"1999","journal-title":"Nature"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB231","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S0167-5699(98)80007-8","article-title":"Much ado about minor histocompatibility antigens","volume":"19","author":"Simpson","year":"1998","journal-title":"Immunol. Today"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB232","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1182\/blood.V89.6.1978","article-title":"Isolation of EBV-specific cytotoxic T lymphocytes that lyse Reed-Sternberg cells: Implications for immune-mediated therapy of EBV+ Hodgkin's disease","volume":"89","author":"Sing","year":"1997","journal-title":"Blood"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB233","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/(SICI)1097-0215(19990827)82:5<669::AID-IJC9>3.0.CO;2-#","article-title":"Mass-spectrometric evaluation of HLA-A*0201-associated peptides identifies dominant naturally processed forms of CTL epitopes MART-1 and gp100","volume":"82","author":"Skipper","year":"1999","journal-title":"Int. J. Cancer"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB234","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1126\/science.3798106","article-title":"Human breast cancer: Correlation of relapse and survival with amplification of the HER-2\/neu oncogene","volume":"235","author":"Slamon","year":"1987","journal-title":"Science"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB235","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1093\/intimm\/10.11.1593","article-title":"High-level IL-12 production by human dendritic cells requires two signals","volume":"10","author":"Snijders","year":"1998","journal-title":"Int. Immunol."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB236","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S1074-7613(00)80641-X","article-title":"Tumor immunology: The glass is half full","volume":"9","author":"Sogn","year":"1998","journal-title":"Immunity"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB237","series-title":"Vaccination with irradiated autologous melanoma cells engineered to secrete human GM-CSF generates potent anti-tumor immunity in patients with metastatic melanoma","first-page":"13141","volume":"95","author":"Soiffer","year":"1998"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB238","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/10503","article-title":"Conversion of tumor-specific CD4+ T cell tolerance to T cell priming through in vivo ligation of CD40","volume":"5","author":"Sotomayor","year":"1999","journal-title":"Nature Med."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB239","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1056\/NEJM199812243392607","article-title":"Antigen localization and migration in immunity and tolerance","volume":"339","author":"Starzl","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB240","first-page":"1178","article-title":"Induction of antigen-specific T cell anergy: An early event in the course of tumor progression","volume":"95","author":"Staveley-O'Carroll","year":"1998"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB241","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1084\/jem.187.8.1349","article-title":"A survey of the humoral immune response of cancer patients to a panel of human tumor antigens","volume":"187","author":"Stockert","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB242","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1002\/(SICI)1521-4141(199812)28:12<4029::AID-IMMU4029>3.0.CO;2-N","article-title":"Generation of the VSV nucleoprotein CTL epitope requires proteasome-dependent and -independent proteolytic activities","volume":"28","author":"Stoltze","year":"1998","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB243","doi-asserted-by":"crossref","first-page":"6136","DOI":"10.1002\/j.1460-2075.1995.tb00304.x","article-title":"Bcl-2 and Fas\/APO-1 regulate distinct pathways to lymphocyte apoptosis","volume":"14","author":"Strasser","year":"1995","journal-title":"EMBO J."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB244","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.4049\/jimmunol.162.8.4790","article-title":"DNA vaccination against the idiotype of a murine B cell lymphoma: Mechanism of tumor protection","volume":"162","author":"Syrengelas","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB245","doi-asserted-by":"crossref","first-page":"5037","DOI":"10.4049\/jimmunol.162.9.5037","article-title":"Cutting edge: 4-1BB is a bona fide CD8 T cell survival signal","volume":"162","author":"Takahashi","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB246","doi-asserted-by":"crossref","first-page":"5500","DOI":"10.4049\/jimmunol.161.10.5500","article-title":"CD4+ lymphocytes provide MUC1-specific tumor immunity in vivo that is undetectable in vitro and is absent in MUC1 transgenic mice","volume":"161","author":"Tempero","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB247","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1084\/jem.188.6.1017","volume":"188","author":"Theobald","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB248","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0167-5699(97)01201-2","article-title":"Gene vaccination: Plasmid DNA is more than just a blueprint","volume":"19","author":"Tighe","year":"1998","journal-title":"Immunol. Today"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB249","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1002\/eji.1830250642","article-title":"Primary proliferative T cell response to wild-type p53 protein in patients with breast cancer","volume":"25","author":"Tilkin","year":"1995","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB250","first-page":"3782","article-title":"Protective anti-tumor immunity induced by immunization with completely allogeneic tumor cells","volume":"56","author":"Toes","year":"1996","journal-title":"Cancer Res."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB251","first-page":"7855","article-title":"Peptide vaccination can lead to enhanced tumor growth through specific tolerance induction","volume":"93","author":"Toes","year":"1996"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB252","doi-asserted-by":"crossref","first-page":"3911","DOI":"10.4049\/jimmunol.156.10.3911","article-title":"Functional deletion of tumor-specific CTL induced by peptide immunization can lead to the inability to reject tumors","volume":"156","author":"Toes","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB253","first-page":"14660","article-title":"Protective anti-tumor immunity induced by vaccination with recombinant adenoviruses encoding multiple tumor-associated cytotoxic T lymphocyte epitopes in a string-of-beads fashion","volume":"94","author":"Toes","year":"1997"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB254","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1006\/smim.1997.0088","article-title":"Activation or frustration of anti-tumor responses by T cell based immune modulation","volume":"9","author":"Toes","year":"1997","journal-title":"Semin. Immunol."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB255","doi-asserted-by":"crossref","first-page":"4449","DOI":"10.4049\/jimmunol.160.9.4449","article-title":"Enhancement of tumor outgrowth through CTL tolerization after peptide vaccination is avoided by peptide presentation on dendritic cells","volume":"160","author":"Toes","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB256","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1006\/smim.1998.0147","article-title":"CD40-CD40 L interactions and their role in CTL priming and anti-tumor immunity","volume":"10","author":"Toes","year":"1998","journal-title":"Semin. Immunol."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB257","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1084\/jem.189.5.753","article-title":"CD4+ T cells and their role in antitumor immune responses","volume":"189","author":"Toes","year":"1999","journal-title":"J. Exp. Med."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB258","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/33712","article-title":"Forced degradation of fas inhibits apoptosis in adenovirus-infected cells","volume":"392","author":"Tollefson","year":"1998","journal-title":"Nature"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB259","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1084\/jem.183.5.1965","article-title":"Melanoma-specific CD4+ T cells recognize non-mutated HLA-DR-restricted tyrosinase epitopes","volume":"183","author":"Topalian","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB260","first-page":"2439","article-title":"Phenotypic stability of a cytotoxic T cell line directed against an immunodominant epitope of human carcinoembryonic antigen","volume":"3","author":"Tsang","year":"1997","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB261","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.4049\/jimmunol.160.3.1139","article-title":"Autologous human monocyte-derived dendritic cells genetically modified to express melanoma antigens elicit primary cytotoxic T cell responses in vitro: Enhancement by cotransfection of genes encoding the Th1-biasing cytokines IL-12 and IFN-alpha","volume":"160","author":"Tuting","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB262","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1046\/j.1365-2141.1998.00982.x","article-title":"Prame, a gene encoding an antigen recognized by cytolytic T cells, is expressed in acute leukaemia cells","volume":"102","author":"Van Baren","year":"1998","journal-title":"Br. J. Haematol."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB263","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1038\/sj.leu.2400797","article-title":"Detection of minimal disease using rearranged immunoglobulin heavy chain genes from intermediate- and high-grade malignant B cell non-Hodgkins lymphoma","volume":"11","author":"Van Belzen","year":"1997","journal-title":"Leukemia"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB264","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S0952-7915(97)80050-7","article-title":"T cell-defined tumor antigens","volume":"9","author":"Van den Eynde","year":"1997","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB265","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.4049\/jimmunol.156.9.3308","article-title":"Immunogenicity of peptides bound to MHC class I molecules depends on the MHC-peptide complex stability","volume":"156","author":"Van der Burg","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB266","series-title":"Cancer","first-page":"514","article-title":"Viral cancer antigens","author":"Van der Burg","year":"1999"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB267","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1002\/eji.1830260803","article-title":"Peptide-pulsed dendritic cells induce tumoricidal cytotoxic T lymphocytes from healthy donors against stably HLA-A*0201 binding peptides from the melan-A\/MART-1 self antigen","volume":"26","author":"Van Elsas","year":"1996","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB268","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1084\/jem.190.3.355","article-title":"Combination immunotherapy of B16 melanoma using anti-CTLA4 and GM-CSF producing vaccines induces rejection of subcutaneous and metastatic tumors accompanied by autoimmune depigmentation","volume":"190","author":"Van Elsas","year":"1999","journal-title":"J. Exp. Med."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB269","first-page":"3087","article-title":"Cryptic open reading frames in plasmid vector backbone sequences can provide highly immunogenic cytotoxic T-lymphocyte epitopes","volume":"58","author":"Van Hall","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB270","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1084\/jem.186.5.695","article-title":"Tumor eradication by wild-type p53-specific cytotoxic T lymphocytes","volume":"186","author":"Vierboom","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB271","series-title":"Peptide-based vaccines","article-title":"p53: A target for T cell-mediated immunotherapy","author":"Vierboom","year":"1999"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB272","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1006\/smim.1998.0157","article-title":"Role of 4-1 BB in immune responses","volume":"10","author":"Vinay","year":"1998","journal-title":"Semin. Immunol."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB273","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.4049\/jimmunol.154.8.3991","article-title":"CTL specific for the tyrosinase autoantigen can be induced from healthy donor blood to lyse melanoma cells","volume":"154","author":"Visseren","year":"1995","journal-title":"J. Immunol."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB274","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1006\/smim.1998.0145","article-title":"CD40 and its crucial role as a member of the TNFR family","volume":"10","author":"Vogel","year":"1998","journal-title":"Semin. Immunol."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB275","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1006\/smim.1998.0146","article-title":"OX-40: Life beyond the effector T cell stage","volume":"10","author":"Weinberg","year":"1998","journal-title":"Semin. Immunol."},{"year":"1999","series-title":"WHO Report of a technical meeting","key":"10.1016\/S0065-2776(00)75006-1_BIB276"},{"key":"10.1016\/S0065-2776(00)75006-1_BIB277","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1084\/jem.188.4.773","article-title":"Glycan-regulated antigen processing of a protein in the endoplasmic reticulum can uncover cryptic CTL epitopes","volume":"188","author":"Wood","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB278","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/10548","article-title":"Cancer therapy using a self-replicating RNA vaccine","volume":"5","author":"Ying","year":"1999","journal-title":"Nature Med."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB279","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1146\/annurev.immunol.14.1.369","article-title":"Antigen processing and presentation by class I major histocompatibility complex","volume":"14","author":"York","year":"1996","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB280","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.4049\/jimmunol.152.5.2393","article-title":"Association of HER2\/neu expression with sensitivity to tumor-specific CTL in human ovarian cancer","volume":"152","author":"Yoshino","year":"1994","journal-title":"J. Immunol."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB281","first-page":"4902","article-title":"Immunization with a peptide epitope (p 369\u2013377) from HER-2\/neu leads to peptide-specific cytotoxic T lymphocytes that fail to recognize HER-2\/neu tumors","volume":"58","author":"Zaks","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB282","first-page":"4570","article-title":"Identification of an enhancer agonist CTL peptide from human carcinoembryonic antigen","volume":"57","author":"Zaremba","year":"1997","journal-title":"Cancer Res."},{"key":"10.1016\/S0065-2776(00)75006-1_BIB283","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1365-3083.1995.tb03696.x","article-title":"Both immunization with protein and recombinant vaccinia virus can stimulate CTL specific for the E7 protein of HPV16","volume":"42","author":"Zhu","year":"1995","journal-title":"Scand. J. Immunol."}],"container-title":["Advances in Immunology","Advances in Immunology Volume 75"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T21:53:22Z","timestamp":1734386002000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0065277600750061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000]]},"ISBN":["9780120224753"],"references-count":283,"URL":"https:\/\/doi.org\/10.1016\/s0065-2776(00)75006-1","relation":{},"ISSN":["0065-2776"],"issn-type":[{"type":"print","value":"0065-2776"}],"subject":[],"published":{"date-parts":[[2000]]}}}